Clinical trial
Imigran STATdose - Japan Clinical Experience Study for Self-injection
NCT00356603 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imigran STATdose - Japan Clinical Experience Study for Self-injection
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 20, 2006
- Completion date
- August 7, 2006
- Enrollment
- 75 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.